Vegan Liftz is a community-supported website. We may earn a small commission on purchases made through our links. Learn more.

Why You Might Want to Try PT 141

Jason Hughes
Published by Jason Hughes
Fact checked by Markus Oliver, BHSc FACT CHECKED
Last updated: June 30, 2022

Sexual libido is not something that is often talked about in social circles, as it is considered a taboo subject. With this being said, it is one of the most searched health and sexually related issues in America, and possibly even globally. Many are ashamed to speak about this with their friends, but having a proper sexual libido is key to a normal and fulfilled lifestyle. In men, this can cause a problem known as Erectile Dysfunction, which has many causes. In women, this issue is not exactly the same, but lack of sexual libido when you should be otherwise aroused is an issue for your physical and mental health.

In this article, we will talk about PT 141 Peptide, a newly researched compound that may be the solution to certain chronic issues that involve physical problems of impotence in both men and women. First, we will aim to define this substance, and then list the purported benefits associated with it. Finally, we will list where to purchase it for approved research and laboratory use.

What is PT-141?

PT-141 is a substance that has recently been approved by the FDA for a specific use but has not been granted full blanket approval as of yet. PT-141 directly targets sexual libido. More specifically, it targets those with a low sexual drive or desire that goes beyond generalized anxiety or mood disorders.

PT-141 is currently approved to be provided for females when diagnosed with generalized hypoactive sexual desire disorder (HSDD) but is not yet currently approved for men.

This is because, unlike other drugs that directly target blood flow, PT-141 tries to get to the root of the problem in those who are not having physical problems as to why their chemical imbalance may be affecting their desire.

PT-141 works by targeting the appropriate receptors in the nerve endings and brain and further stimulates the desire to have sexual intercourse with your partner. It is originally developed by Palatin technologies and funded the initial clinical studies which led to the initial approval of the FDA for the use in the treatment of females with diagnosed low libido. It is currently legal to be sold for this purpose, otherwise, it is only legal for approved research and laboratory purposes.

What are The Benefits of PT 141 Nasal Spray?

PT 141 is a peptide that is normally administered through the nose, as it helps to target the brain and nervous system easily. The spray has many benefits, but most of them are only observed in women where the drug can be given legally:

Increases Sexual Desire (female): As stated previously, PT 141 can be given legally to women with generalized hypoactive sexual desire disorder (HSDD). It increases the desire in patients as observed through phase 2 and 3 clinical trials as well as being administered as a prescription. It is recommended for women to take about 1-2 hours before the expected intercourse (does anyone schedule this?) for maximum benefit. It works by stimulating your receptors' release of dopamine, which is the drug that makes you "want more".

Increases Sexual Satisfaction (female and male): PT 141 has been tested in both men and women and observed a significant increase in satisfaction post-intercourse. Initially, 1.25mg was given but there was an even more notable increase when an additional 1.75mg was given. Of particular interest to the researchers was the sudden increase in desire for premenopausal women, who are known for being increasingly dissatisfied due to their hormonal fluctuations during this period.

Reduces Distress (female): Women who experience mental distress due to their lack of libido saw an increase in their confidence and satisfaction pre and post-intercourse. While this may have been entirely a psychological effect, it is interesting to note that those who were administered a placebo felt more distress than those who took PT 141. It is still being studied as to why this occurs, but it is generally accepted that the sudden feeling of desire throughout long periods of suffering through a hypoactive libido will bring about hope and confidence.

Potential treatment for ED (male): There are three main causes of erectile dysfunction; psychological, libido, and physically related. To date, drugs such as Viagara dominate the market for those that are having physical issues, or as an alternative to overpower the feelings of anxiety and lack of libido within. Although Pt 141 does not assist with physical problems related to blood or muscles, through trials it is extremely effective in helping raise libido levels, as well as helping to reduce anxious thoughts pre-intercourse.

Where Can I Get PT 141 Peptide?

PureRawz is the leading supplier of peptides, SARMs, nootropics, and other supplements that are related to sexual health, fitness, weight loss, and other related things. They source only the best quality, provide disclaimers, and also display all necessary information with regards to sourcing, shipping, and ingredients contained within. Please note that this item is available for sale only on the basis that you are using it for approved research or laboratory use.


Is pt 141 a sarm?

No. PT 141 is a peptide called Bremelanotide. While it works similarly to the way SARMs bind to androgenic receptors, PT 141 does not have any sway on the androgenic parts of the muscles or body. It works by activating receptors within the nervous system and brain to increase the release of dopamine, which helps to stimulate healthy sexual desire.

What are the side effects of pt 141?

Side effects can include nausea, vomiting, cough, headache, dizziness, brushing, high blood pressure, and itching of the administration site.

PT 141 is currently approved for use in the treatment of females diagnosed with low libido disorder. It is not currently approved for use in the treatment of low libido in otherwise healthy males, although studies are being conducted continuously to hopefully achieve this.


About the author